These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37605987)

  • 1. Cytokines, chemokines, and cells growth factors in patients with mild to moderate SARS-CoV-2 infection: A case-control study.
    Gondim RNDG; de Arruda EAG; Neto RDJP; Medeiros MS; Quirino-Filho J; Clementino MA; Magalhães LMVC; Cavalcante KF; Viana VAF; Mello LP; Carlos LMB; Havt A; Lima AAM
    J Med Virol; 2023 Aug; 95(8):e29044. PubMed ID: 37605987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High levels of pro-inflammatory SARS-CoV-2-specific biomarkers revealed by in vitro whole blood cytokine release assay (CRA) in recovered and long-COVID-19 patients.
    Gomes SMR; Brito ACS; Manfro WFP; Ribeiro-Alves M; Ribeiro RSA; da Cal MS; Lisboa VDC; Abreu DPB; Castilho LDR; Porto LCMS; Mafort TT; Lopes AJ; da Silva SAG; Dutra PML; Rodrigues LS
    PLoS One; 2023; 18(4):e0283983. PubMed ID: 37018291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients.
    Normandin E; Holroyd KB; Collens SI; Shaw BM; Siddle KJ; Adams G; Rudy M; Solomon IH; Anahtar MN; Lemieux JE; Trombetta BA; Kivisakk P; Arnold SE; Rapalino O; Piantadosi AL; Sen P; Rosenberg ES; Branda J; Sabeti PC; Mukerji SS
    J Neurol Sci; 2021 Nov; 430():120023. PubMed ID: 34678659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proinflammatory Cytokine Profiles in Both Mild Symptomatic and Asymptomatic SARS-CoV-2-Infected Egyptian Individuals and a Proposed Relationship to Post-COVID-19 Sequela.
    Bahgat MM; Nadeem R; Nasraa MH; Amer K; Hassan WA; ELGarhy FM; Reda S; Abd-Elshafy DN
    Viral Immunol; 2023 Nov; 36(9):600-609. PubMed ID: 37831918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of supervised physical exercise on chemokines and cytokines in recovered COVID-19 patients.
    Filgueira TO; Carvalho PRC; de Sousa Fernandes MS; Castoldi A; Teixeira AM; de Albuquerque RB; de Lima-Filho JL; Souto FO
    Front Immunol; 2022; 13():1051059. PubMed ID: 36685603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum profiles of pro-inflammatory and anti-inflammatory cytokines in non-hospitalized patients with mild/moderate COVID-19 infection.
    Majeed AY; Zulkafli NES; Ad'hiah AH
    Immunol Lett; 2023 Aug; 260():24-34. PubMed ID: 37339685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid cytokine, chemokine, and SARS-CoV-2 antibody profiles in children with neuropsychiatric symptoms associated with COVID-19.
    Ngo B; Lapp SA; Siegel B; Patel V; Hussaini L; Bora S; Philbrook B; Weinschenk K; Wright L; Anderson EJ; Rostad CA; Gombolay GY
    Mult Scler Relat Disord; 2021 Oct; 55():103169. PubMed ID: 34333272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Innate and Adaptive Cytokines in the Survival of COVID-19 Patients.
    Monserrat J; Gómez-Lahoz A; Ortega MA; Sanz J; Muñoz B; Arévalo-Serrano J; Rodríguez JM; Gasalla JM; Gasulla Ó; Arranz A; Fortuny-Profitós J; Mazaira-Font FA; Teixidó Román M; Martínez-A C; Balomenos D; Asunsolo A; Álvarez-Mon M; On Behalf Of The Covid-Hupa Group
    Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement Anaphylatoxins and Inflammatory Cytokines as Prognostic Markers for COVID-19 Severity and In-Hospital Mortality.
    Alosaimi B; Mubarak A; Hamed ME; Almutairi AZ; Alrashed AA; AlJuryyan A; Enani M; Alenzi FQ; Alturaiki W
    Front Immunol; 2021; 12():668725. PubMed ID: 34276659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-inflammatory CXCL-10, TNF-α, IL-1β, and IL-6: biomarkers of SARS-CoV-2 infection.
    Tripathy AS; Vishwakarma S; Trimbake D; Gurav YK; Potdar VA; Mokashi ND; Patsute SD; Kaushal H; Choudhary ML; Tilekar BN; Sarje P; Dange VS; Abraham P
    Arch Virol; 2021 Dec; 166(12):3301-3310. PubMed ID: 34554303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of serum IL-10, IL-1β, IL-6, MCP-1, TNF-α, IP-10 and IL-4 in COVID-19 patients.
    Lu Q; Zhu Z; Tan C; Zhou H; Hu Y; Shen G; Zhu P; Yang G; Xie X
    Int J Clin Pract; 2021 Sep; 75(9):e14462. PubMed ID: 34107113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate Pre-Partum SARS-CoV-2 Status and Immune Profiling of Breastmilk: A Case-Control Study.
    Sánchez García L; Gómez-Torres N; Cabañas F; González-Sánchez R; López-Azorín M; Moral-Pumarega MT; Escuder-Vieco D; Cabañes-Alonso E; Castro I; Alba C; Rodríguez Gómez JM; Pellicer A
    Front Immunol; 2021; 12():720716. PubMed ID: 34381462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between inflammatory cytokines/chemokines, clinical laboratory parameters, disease severity and in-hospital mortality in critical and mild COVID-19 patients without comorbidities or immune-mediated diseases.
    Hamza M; Alhujaily M; Alosaimi B; El Bakkouri K; AlDughaim MS; Alonazi M; Alanazi MA; Abbass B; Alshehri A; Al-Shouli ST; Alturaiki W; Awadalla M
    J Immunoassay Immunochem; 2023 Jan; 44(1):13-30. PubMed ID: 35915975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine Profiles Associated With Worse Prognosis in a Hospitalized Peruvian COVID-19 Cohort.
    Pons MJ; Ymaña B; Mayanga-Herrera A; Sáenz Y; Alvarez-Erviti L; Tapia-Rojas S; Gamarra R; Blanco AB; Moncunill G; Ugarte-Gil MF
    Front Immunol; 2021; 12():700921. PubMed ID: 34539631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers of oxidative stress and inflammation in subjects with COVID-19: Characterization and prognosis of the disease.
    Coronel PMV; Pereira IC; Basilio DCLS; Espinoça IT; de Souza KFS; Ota RSN; de Almeida EB; Paredes-Gamero EJ; Wilhelm Filho D; Perdomo RT; Parisotto EB
    Microb Pathog; 2023 Nov; 184():106339. PubMed ID: 37690769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Galectin-9, a Player in Cytokine Release Syndrome and a Surrogate Diagnostic Biomarker in SARS-CoV-2 Infection.
    Bozorgmehr N; Mashhouri S; Perez Rosero E; Xu L; Shahbaz S; Sligl W; Osman M; Kutsogiannis DJ; MacIntyre E; O'Neil CR; Elahi S
    mBio; 2021 May; 12(3):. PubMed ID: 33947753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine profiles of mild-to-moderate SARS-CoV-2 infected and recovered pre-vaccinated individuals residing in Indonesia.
    Megasari NLA; Khairunisa SQ; Arizandy RY; Wijaksana IKE; Wungu CDK
    PeerJ; 2024; 12():e17257. PubMed ID: 38646483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Panoramic snapshot of serum soluble mediator interplay in pregnant women with convalescent COVID-19: an exploratory study.
    Fernandes GM; Sasaki LMP; Jardim-Santos GP; Schulte HL; Motta F; da Silva ÂP; de Carvalho AO; Pereira YR; Alves CO; de Araújo Júnior DA; Mendonça-Silva DL; Costa KN; de Castro MEC; Lauand L; Nery RR; Tristão R; Kurizky PS; Nóbrega OT; Espindola LS; de Castro LCG; Alpoim PN; Godoi LC; Dusse LMSA; Coelho-Dos-Reis JGA; do Amaral LR; Gomes MS; Bertarini PLL; Brito-de-Sousa JP; da Costa-Rocha IA; Campi-Azevedo AC; Peruhype-Magalhães V; Teixeira-Carvalho A; Zaconeta AM; Soares AASM; Valim V; Gomes CM; de Albuquerque CP; Martins-Filho OA; da Mota LMH
    Front Immunol; 2023; 14():1176898. PubMed ID: 37122732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic SARS-CoV-2 Infection Is Associated With Higher Levels of Serum IL-17C, Matrix Metalloproteinase 10 and Fibroblast Growth Factors Than Mild Symptomatic COVID-19.
    Soares-Schanoski A; Sauerwald N; Goforth CW; Periasamy S; Weir DL; Lizewski S; Lizewski R; Ge Y; Kuzmina NA; Nair VD; Vangeti S; Marjanovic N; Cappuccio A; Cheng WS; Mofsowitz S; Miller CM; Yu XB; George MC; Zaslavsky E; Bukreyev A; Troyanskaya OG; Sealfon SC; Letizia AG; Ramos I
    Front Immunol; 2022; 13():821730. PubMed ID: 35479098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.